Published in J Diabetes Res on August 06, 2015
Orai1-Mediated Antimicrobial Secretion from Pancreatic Acini Shapes the Gut Microbiome and Regulates Gut Innate Immunity. Cell Metab (2017) 1.39
Engineered Resistant-Starch (ERS) Diet Shapes Colon Microbiota Profile in Parallel with the Retardation of Tumor Growth in In Vitro and In Vivo Pancreatic Cancer Models. Nutrients (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35
Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell (2004) 29.32
The human microbiome project. Nature (2007) 28.53
Immunity, inflammation, and cancer. Cell (2010) 28.27
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
Comparative metagenomics of microbial communities. Science (2005) 25.88
The NIH Human Microbiome Project. Genome Res (2009) 24.61
Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A (1998) 21.41
Pattern recognition receptors and inflammation. Cell (2010) 21.05
Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol (1977) 17.41
Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2010) 16.71
Defining the normal bacterial flora of the oral cavity. J Clin Microbiol (2005) 15.75
STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer (2009) 15.45
High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med (2001) 12.49
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature (2010) 10.60
Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet (2009) 10.02
FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol (2010) 8.73
Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell (2007) 8.47
The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett (2002) 7.29
Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 6.86
Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol (2004) 6.78
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature (2013) 6.77
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut (2009) 6.50
Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One (2010) 6.48
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature (2013) 6.45
Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci (1995) 6.36
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 5.47
Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther (2007) 5.47
Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science (2013) 5.09
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60
Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med (2009) 4.48
Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology (2001) 4.44
Acute pancreatitis. Lancet (2008) 4.13
New bacterial species associated with chronic periodontitis. J Dent Res (2003) 4.03
The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology (2013) 3.89
Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc (1991) 3.88
The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med (1994) 3.71
Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med (2007) 3.48
Role of the microbiota in immunity and inflammation. Cell (2014) 3.43
The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res (1999) 3.36
DAMPening inflammation by modulating TLR signalling. Mediators Inflamm (2010) 3.29
Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia (2006) 3.21
Retracted Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol (2011) 3.02
An ultrastructural analysis of the developing embryonic pancreas. Dev Biol (1972) 3.00
NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest (2013) 2.96
Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab (2003) 2.92
Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care (2009) 2.91
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med (2012) 2.86
The microbiome and cancer. Nat Rev Cancer (2013) 2.86
Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One (2009) 2.79
Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med (2008) 2.79
The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes (2008) 2.77
Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest (2011) 2.77
Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed (2000) 2.70
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
Trends in the epidemiology of the first attack of acute pancreatitis: a systematic review. Pancreas (2006) 2.62
Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) (2008) 2.46
Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia (2012) 2.41
A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J Natl Cancer Inst (2007) 2.40
Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut (2011) 2.38
Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol (2012) 2.35
Cdc42-mediated tubulogenesis controls cell specification. Cell (2009) 2.35
AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology (1999) 2.34
Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses. Sci Transl Med (2012) 2.33
Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst (2001) 2.32
Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas (2003) 2.26
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med (2011) 2.25
Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes (2012) 2.22
Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One (2011) 2.18
Diabetes and gender. Diabetologia (2001) 2.17
An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest (2012) 2.13
Granulicatella adiacens and Abiotrophia defectiva bacteraemia characterized by 16S rRNA gene sequencing. J Med Microbiol (2003) 2.07
Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab (1999) 2.06
Debugging how bacteria manipulate the immune response. Immunity (2007) 2.06
Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One (2008) 2.04
Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem Biophys Res Commun (2009) 2.04
Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia (2005) 2.03
Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice. Gut (2009) 2.01
The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J Biol Chem (2000) 1.87
Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun (2013) 1.85
Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia (2012) 1.83
MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. J Exp Med (2012) 1.82
Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg (2000) 1.77
Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J (2009) 1.74
Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes (2014) 1.74
Enteric flora in health and disease. Digestion (2006) 1.70
Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity. Gastroenterology (2014) 1.70
Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One (2010) 1.70
Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci Transl Med (2014) 1.69
Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology (2010) 1.61
An exploration of the periodontitis-cancer association. Ann Epidemiol (2003) 1.59
Toll-like receptor signaling pathways. Front Immunol (2014) 1.58
Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas (2006) 1.58
Genetic determinants of pancreatic epsilon-cell development. Dev Biol (2005) 1.54
ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst (2010) 1.54
Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J Dent Res (2006) 1.52
Less common neoplasms of the pancreas. World J Gastroenterol (2006) 1.52